Kenneth L. Fan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Kenneth L. Fan has a total of 443 co-authors. Here are the top co-authors by number of shared publications:
- Karen Kim Evans
Department of Plastic and Reconstructive Surgery, Medstar Georgetown University Hospital, Washington, DC 20007, USA
19 shared publications Cara K. Black
Georgetown University School of Medicine Washington DC USA
16 shared publicationsDavid H. Song
Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital
13 shared publications- Jenna C. Bekeny
Department of Plastic and Reconstructive Surgery
12 shared publications Kyle Luvisa
Georgetown University School of Medicine Washington DC USA
10 shared publications- Christopher E. Attinger
Department of Plastic and Reconstructive Surgery, Medstar Georgetown University Hospital, Washington, DC 20007, USA
8 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 14 (6) , e7881
Battle of the Brands: A Multicenter Comparative Analysis of Outcomes in Immediate Implant-based Breast Reconstruction With Acellular Dermal Matrices
Background: We conducted a head-to-head study comparing outcomes among commonly used implant brands, Allergan, Mentor, and Sientra, used in breast reconstruction. Methods: A multicenter retrospective review of patients undergoing acellular dermal matrix–assisted implant-based breast reconstruction (IBR) with Allergan, Mentor, or Sientra implants between January 2014 and July 2022 was conducted. Primary outcomes included rates of return to the operating room for implant removal. Secondary outcomes included complications occurring within 30 days, between 31 and 60 days, and after 60 days. Results: A total of 631 patients (1155 breasts) underwent IBR: Allergan (n = 280 breasts, 24.2%), Mentor (n = 714, 61.7%), Sientra (n = 161, 13.9%). Mean age was 49.2 ± 11.4 years. Mean body mass index was 25.6 ± 5.4 kg/m 2 . One hundred ninety-nine (17.2%) breasts underwent adjuvant radiation and 168 (14.5%) underwent neoadjuvant chemotherapy. Implants were most often inserted in the prepectoral plane (n = 584, 50.6%). After 60 days, there were no significant differences in overall complication rates between brands. One hundred sixty-one (13.9%) breasts underwent eventual reoperation, including unplanned explantation (n = 95, 8.2%), elective revision (n = 94, 8.1%), oncological indications (n = 20, 1.7%), and infection (n = 15, 1.3%). Indications for unplanned explantation included infection (n = 26, 2.3%), capsular contracture (n = 15, 1.3%), and nonhealing wounds (n = 14, 1.2%). There were no differences in other complications or reoperations between cohorts. Body mass index, diabetes mellitus, smoking history, chemotherapy, radiation, skin-sparing mastectomy, type of incision, and tissue expander use were independent predictors of postoperative complications. Conclusions: Low rates of complications among Allergan, Mentor, and Sientra implants in IBR support their continued use. No single brand was superior to others regarding complication profile in our study. Patient characteristics and operative approach seem more predictive of postoperative outcomes than the implant brand alone.
- 1 June 2026
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 14 (6) , e7881
Open AccessBattle of the Brands: A Multicenter Comparative Analysis of Outcomes in Immediate Implant-based Breast Reconstruction With Acellular Dermal Matrices
Background: We conducted a head-to-head study comparing outcomes among commonly used implant brands, Allergan, Mentor, and Sientra, used in breast reconstruction. Methods: A multicenter retrospective review of patients undergoing acellular dermal matrix–assisted implant-based breast reconstruction (IBR) with Allergan, Mentor, or Sientra implants between January 2014 and July 2022 was conducted. Primary outcomes included rates of return to the operating room for implant removal. Secondary outcomes included complications occurring within 30 days, between 31 and 60 days, and after 60 days. Results: A total of 631 patients (1155 breasts) underwent IBR: Allergan (n = 280 breasts, 24.2%), Mentor (n = 714, 61.7%), Sientra (n = 161, 13.9%). Mean age was 49.2 ± 11.4 years. Mean body mass index was 25.6 ± 5.4 kg/m 2 . One hundred ninety-nine (17.2%) breasts underwent adjuvant radiation and 168 (14.5%) underwent neoadjuvant chemotherapy. Implants were most often inserted in the prepectoral plane (n = 584, 50.6%). After 60 days, there were no significant differences in overall complication rates between brands. One hundred sixty-one (13.9%) breasts underwent eventual reoperation, including unplanned explantation (n = 95, 8.2%), elective revision (n = 94, 8.1%), oncological indications (n = 20, 1.7%), and infection (n = 15, 1.3%). Indications for unplanned explantation included infection (n = 26, 2.3%), capsular contracture (n = 15, 1.3%), and nonhealing wounds (n = 14, 1.2%). There were no differences in other complications or reoperations between cohorts. Body mass index, diabetes mellitus, smoking history, chemotherapy, radiation, skin-sparing mastectomy, type of incision, and tissue expander use were independent predictors of postoperative complications. Conclusions: Low rates of complications among Allergan, Mentor, and Sientra implants in IBR support their continued use. No single brand was superior to others regarding complication profile in our study. Patient characteristics and operative approach seem more predictive of postoperative outcomes than the implant brand alone.
- Open Access
- 10 May 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 118, 146-152
The impact of marijuana use on postoperative outcomes in reduction mammaplasty: Risks, complications, and considerations
- 10 May 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 118, 146-152
Open AccessThe impact of marijuana use on postoperative outcomes in reduction mammaplasty: Risks, complications, and considerations
- Open Access
- 1 May 2026
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 14 (5) , e7728
Acellular Dermal Matrix–assisted Implant-based Breast Reconstruction: Surgical and Patient-reported Outcomes From the Mastectomy Reconstruction Outcomes Consortium Study
Background: Acellular dermal matrices (ADMs) are used in most of the United States but are not FDA-approved for this indication. We evaluated SurgiMend (Integra) in immediate 2-stage subpectoral reconstruction versus no ADM. Methods: An FDA-aligned statistical analysis plan was applied to the prospective Mastectomy Reconstruction Outcomes Consortium cohort. Patients underwent 2-stage subpectoral implant-based breast reconstruction with SurgiMend or without ADM. BREAST-Q Physical Well-Being (Chest) scores were collected preoperatively and at 1 week, 3 months, 1 year, and 2 years. The primary outcome was composite clinical success, defined as a decline in BREAST-Q score of 4 point or less at 1 year and no major complication within 2 years. Results: Among 987 patients, 119 (12.1%) received SurgiMend and 868 (87.9%) underwent reconstruction without ADM. Mean age was 48.1±10.4 years. Mean body mass index was 25.8±5.3 kg/m 2 . Most patients underwent mastectomy for cancer (SurgiMend 85.7%; control 92.9%); nearly half underwent prophylactic procedures (SurgiMend 47.9%; control 52.9%). At 1 year, BREAST-Q scores were higher in the SurgiMend group (44.5% versus 39.1%; difference 5.4%, 95% CI −5.2 to 16.0). In propensity-adjusted analyses, major complications were lower with SurgiMend (33.7% versus 46.7%; difference −13.1%, 95% CI −22.5 to −3.7). Composite clinical success was significantly higher with SurgiMend (32.4% versus 21.1%; difference 11.2%, 95% CI 1.7 to 20.8; P = 0.02). Conclusions: SurgiMend was associated with fewer complications and higher patient-reported outcomes, supporting its safety and effectiveness in postmastectomy reconstruction.
- 1 May 2026
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 14 (5) , e7728
Open AccessAcellular Dermal Matrix–assisted Implant-based Breast Reconstruction: Surgical and Patient-reported Outcomes From the Mastectomy Reconstruction Outcomes Consortium Study
Background: Acellular dermal matrices (ADMs) are used in most of the United States but are not FDA-approved for this indication. We evaluated SurgiMend (Integra) in immediate 2-stage subpectoral reconstruction versus no ADM. Methods: An FDA-aligned statistical analysis plan was applied to the prospective Mastectomy Reconstruction Outcomes Consortium cohort. Patients underwent 2-stage subpectoral implant-based breast reconstruction with SurgiMend or without ADM. BREAST-Q Physical Well-Being (Chest) scores were collected preoperatively and at 1 week, 3 months, 1 year, and 2 years. The primary outcome was composite clinical success, defined as a decline in BREAST-Q score of 4 point or less at 1 year and no major complication within 2 years. Results: Among 987 patients, 119 (12.1%) received SurgiMend and 868 (87.9%) underwent reconstruction without ADM. Mean age was 48.1±10.4 years. Mean body mass index was 25.8±5.3 kg/m 2 . Most patients underwent mastectomy for cancer (SurgiMend 85.7%; control 92.9%); nearly half underwent prophylactic procedures (SurgiMend 47.9%; control 52.9%). At 1 year, BREAST-Q scores were higher in the SurgiMend group (44.5% versus 39.1%; difference 5.4%, 95% CI −5.2 to 16.0). In propensity-adjusted analyses, major complications were lower with SurgiMend (33.7% versus 46.7%; difference −13.1%, 95% CI −22.5 to −3.7). Composite clinical success was significantly higher with SurgiMend (32.4% versus 21.1%; difference 11.2%, 95% CI 1.7 to 20.8; P = 0.02). Conclusions: SurgiMend was associated with fewer complications and higher patient-reported outcomes, supporting its safety and effectiveness in postmastectomy reconstruction.
- Open Access
- 1 September 2025
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 13 (9) , e7106
“Going Flat”: Aesthetic Flat Closure as a Breast Reconstruction Option in Gender-nonconforming Patients
Summary: Patients who desire a flatter chest contour after mastectomy can opt for aesthetic flat closure (AFC) instead of traditional autologous and breast implant options that recreate the breast mound. AFC is an evolving area of reconstructive surgery in breast reconstruction, and there have been no nipple-sparing techniques demonstrated in the current literature to date. We thus present an AFC surgical technique by the senior author for the oncoplastic gender-nonconforming patient population. Technically, this approach uses an inferior adipodermal flap to preserve the nipple–areola complex, similar to an inferior pedicle-based reduction mammaplasty, while achieving a masculinized chest contour. Key surgical pearls include preoperative planning to align patient goals with chest wall aesthetics, careful intraoperative assessment to ensure adequate nipple perfusion, and intraoperative flexibility in nipple resizing, reshaping, and repositioning to align with the patient’s wishes. The technique also allows for customization of chest contour, enabling the creation of a completely flat chest or a small breast mound based on individual patients’ preferences. Patients requiring extensive tissue removal or contraindications for breast-conserving surgery should be excluded due to the risk of inadequate nipple perfusion. This is the first and only nipple-sparing AFC technique in the current literature, addressing a need in reconstructive breast surgery for gender-nonconforming populations.
- 1 September 2025
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 13 (9) , e7106
Open Access“Going Flat”: Aesthetic Flat Closure as a Breast Reconstruction Option in Gender-nonconforming Patients
Summary: Patients who desire a flatter chest contour after mastectomy can opt for aesthetic flat closure (AFC) instead of traditional autologous and breast implant options that recreate the breast mound. AFC is an evolving area of reconstructive surgery in breast reconstruction, and there have been no nipple-sparing techniques demonstrated in the current literature to date. We thus present an AFC surgical technique by the senior author for the oncoplastic gender-nonconforming patient population. Technically, this approach uses an inferior adipodermal flap to preserve the nipple–areola complex, similar to an inferior pedicle-based reduction mammaplasty, while achieving a masculinized chest contour. Key surgical pearls include preoperative planning to align patient goals with chest wall aesthetics, careful intraoperative assessment to ensure adequate nipple perfusion, and intraoperative flexibility in nipple resizing, reshaping, and repositioning to align with the patient’s wishes. The technique also allows for customization of chest contour, enabling the creation of a completely flat chest or a small breast mound based on individual patients’ preferences. Patients requiring extensive tissue removal or contraindications for breast-conserving surgery should be excluded due to the risk of inadequate nipple perfusion. This is the first and only nipple-sparing AFC technique in the current literature, addressing a need in reconstructive breast surgery for gender-nonconforming populations.
- Open Access
- 1 September 2025
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 13 (9) , e7129
The Role of Decision Aids and Soft Tissue Simulations in Breast Reduction Surgery: A Pilot Study
Summary: In this study, we aimed to assess the impact of soft tissue simulations as a decision aid on BREAST-Q outcomes after breast reduction surgery. A total of 7 patients underwent breast reduction. The mean BREAST-Q scores at baseline and 6 months showed significant differences in the domains of satisfaction with breasts (20.1 ± 10.1 versus 78.3 ± 8.1; P < 0.001), psychosocial well-being (29.2 ± 12.2 versus 81.2 ± 9.0; P < 0.001), sexual well-being (29.0 ± 14.5 versus 74.0 ± 12.3; P < 0.001), and physical well-being (40.2 ± 14.3 versus 78.6 ± 10.2; P < 0.001). When patients were asked, “On a scale of 1 to 10, how challenging do you find the decision-making process for selecting a postoperative breast cup size?” the mean score was 9.6 ± 0.5. When asked, “How helpful are these images in helping you choose your preferred breast cup size?” all respondents selected “extremely helpful” (n = 10, 100.0%). This pilot study supported the use of soft tissue simulations as a decision aid to improve patient satisfaction.
- 1 September 2025
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 13 (9) , e7129
Open AccessThe Role of Decision Aids and Soft Tissue Simulations in Breast Reduction Surgery: A Pilot Study
Summary: In this study, we aimed to assess the impact of soft tissue simulations as a decision aid on BREAST-Q outcomes after breast reduction surgery. A total of 7 patients underwent breast reduction. The mean BREAST-Q scores at baseline and 6 months showed significant differences in the domains of satisfaction with breasts (20.1 ± 10.1 versus 78.3 ± 8.1; P < 0.001), psychosocial well-being (29.2 ± 12.2 versus 81.2 ± 9.0; P < 0.001), sexual well-being (29.0 ± 14.5 versus 74.0 ± 12.3; P < 0.001), and physical well-being (40.2 ± 14.3 versus 78.6 ± 10.2; P < 0.001). When patients were asked, “On a scale of 1 to 10, how challenging do you find the decision-making process for selecting a postoperative breast cup size?” the mean score was 9.6 ± 0.5. When asked, “How helpful are these images in helping you choose your preferred breast cup size?” all respondents selected “extremely helpful” (n = 10, 100.0%). This pilot study supported the use of soft tissue simulations as a decision aid to improve patient satisfaction.
- Open Access
- 30 April 2025
- Published by SAGE Publications in Advances in Wound Care
- Vol. 14 (5) , 238-250
The WOUND-Q Function and Symptoms Scales for Chronic Lower Extremity Wounds: A Validation Study
Objective: Determine the validity and reliability of the LIMB-Q scales, Function, and Symptoms in patients with chronic lower extremity wounds. Approach: Cognitive debriefing interviews with people with current or previous wounds were conducted to examine content validity. Scales were field-tested in an international sample of people with chronic lower extremity wounds sourced from an online platform ( i.e., Prolific). Psychometric properties were examined using the Rasch Measurement Theory analysis. A test–retest reproducibility study was performed, and construct validity was examined. Results: Content validity was established after 10 cognitive interviews. A total of 233 people with lower extremity wounds (age 19–80 years, mean 39.3) participated in the field test. All 25 items tested demonstrated good fit to the Rasch model with ordered thresholds. One item had a fit residual outside ±2.5, but no items had significant χ 2 values after Bonferroni adjustment. Reliability was high with the person separation index, Cronbach alpha, and intraclass correlation coefficient values >0.8. Strong correlations were found between the Function and Symptoms scales and EQ-5D dimensions measuring similar constructs as well as the EQ-5D global score. All hypotheses for construct validity were confirmed. Innovation: Patient-reported outcome measures are an important component of patient-centered care, as they capture the patient’s perspective in a rigorous and reproducible way. Adding these two scales to the WOUND-Q provides a means to measure function and symptoms associated with lower extremity wounds. Conclusion: These new WOUND-Q scales can be used to measure outcomes important to patients with lower extremity wounds in clinical settings and research studies.
- 30 April 2025
- Published by SAGE Publications in Advances in Wound Care
- Vol. 14 (5) , 238-250
Open AccessThe WOUND-Q Function and Symptoms Scales for Chronic Lower Extremity Wounds: A Validation Study
Objective: Determine the validity and reliability of the LIMB-Q scales, Function, and Symptoms in patients with chronic lower extremity wounds. Approach: Cognitive debriefing interviews with people with current or previous wounds were conducted to examine content validity. Scales were field-tested in an international sample of people with chronic lower extremity wounds sourced from an online platform ( i.e., Prolific). Psychometric properties were examined using the Rasch Measurement Theory analysis. A test–retest reproducibility study was performed, and construct validity was examined. Results: Content validity was established after 10 cognitive interviews. A total of 233 people with lower extremity wounds (age 19–80 years, mean 39.3) participated in the field test. All 25 items tested demonstrated good fit to the Rasch model with ordered thresholds. One item had a fit residual outside ±2.5, but no items had significant χ 2 values after Bonferroni adjustment. Reliability was high with the person separation index, Cronbach alpha, and intraclass correlation coefficient values >0.8. Strong correlations were found between the Function and Symptoms scales and EQ-5D dimensions measuring similar constructs as well as the EQ-5D global score. All hypotheses for construct validity were confirmed. Innovation: Patient-reported outcome measures are an important component of patient-centered care, as they capture the patient’s perspective in a rigorous and reproducible way. Adding these two scales to the WOUND-Q provides a means to measure function and symptoms associated with lower extremity wounds. Conclusion: These new WOUND-Q scales can be used to measure outcomes important to patients with lower extremity wounds in clinical settings and research studies.
- Open Access
- 4 March 2025
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 156 (3) , 369-382
Is Preoperative Happiness Influencing BREAST-Q Outcomes?
Background: The BREAST-Q captures the quality-of-life implications of breast reconstruction, but may draw influence from the patients’ psychosocial circumstances. This study examined whether positive affect is associated with higher breast satisfaction and well-being, and whether socioeconomic status affects this relationship. Methods: This prospective study included patients undergoing breast reconstruction from August of 2020 to October of 2022. The Cantril Ladder of Happiness was used to assess happiness (1 to 5, unhappy; 6 to 10, happy). The BREAST-Q was sent before surgery and 1, 3, 6, and 12 months after surgery. Patient characteristics, oncologic treatments, perioperative details, and outcomes were collected. Results: A total of 49 participants (65.3%) identified themselves as happy and 26 (34.8%) as unhappy. Happy patients were more likely to have current employment (73.5% versus 57.7%; P = 0.039) and “a lot” of social network support (53.1% versus 50.0%; P = 0.045). Happy patients reported higher satisfaction with their breasts at baseline (53.7 ± 23.9 versus 40.0 ± 40.1; P = 0.029) and 3 months (61.1 ± 20.1 versus 47.8 ± 8.5; P = 0.003); higher psychosocial well-being at baseline (69.8 ± 17.3 versus 52.8 ± 18.8; P < 0.001) and 3 months (73.8 ± 20.5 versus 60.4 ± 18.8; P = 0.047); and higher sexual well-being at 3 months (57.5 ± 28.0 versus 33.4 ± 17.7; P = 0.007) and 1 year (63.1 ± 24.0 versus 34.6 ± 21.8; P = 0.043). Patients with higher Cantril Ladder of Happiness scores reported higher psychosocial well-being (β = 12.9; P < 0.001) and sexual well-being (β = 16.94; P < 0.001). Conclusions: Happy patients demonstrated higher satisfaction levels and improved psychosocial and sexual well-being compared with unhappy patients. SES played a role in patient satisfaction and overall well-being. Further research is warranted to identify suitable interventions, such as screening and early referral, that can help improve patient-reported outcomes for patients undergoing breast reconstruction.
- 4 March 2025
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 156 (3) , 369-382
Open AccessIs Preoperative Happiness Influencing BREAST-Q Outcomes?
Background: The BREAST-Q captures the quality-of-life implications of breast reconstruction, but may draw influence from the patients’ psychosocial circumstances. This study examined whether positive affect is associated with higher breast satisfaction and well-being, and whether socioeconomic status affects this relationship. Methods: This prospective study included patients undergoing breast reconstruction from August of 2020 to October of 2022. The Cantril Ladder of Happiness was used to assess happiness (1 to 5, unhappy; 6 to 10, happy). The BREAST-Q was sent before surgery and 1, 3, 6, and 12 months after surgery. Patient characteristics, oncologic treatments, perioperative details, and outcomes were collected. Results: A total of 49 participants (65.3%) identified themselves as happy and 26 (34.8%) as unhappy. Happy patients were more likely to have current employment (73.5% versus 57.7%; P = 0.039) and “a lot” of social network support (53.1% versus 50.0%; P = 0.045). Happy patients reported higher satisfaction with their breasts at baseline (53.7 ± 23.9 versus 40.0 ± 40.1; P = 0.029) and 3 months (61.1 ± 20.1 versus 47.8 ± 8.5; P = 0.003); higher psychosocial well-being at baseline (69.8 ± 17.3 versus 52.8 ± 18.8; P < 0.001) and 3 months (73.8 ± 20.5 versus 60.4 ± 18.8; P = 0.047); and higher sexual well-being at 3 months (57.5 ± 28.0 versus 33.4 ± 17.7; P = 0.007) and 1 year (63.1 ± 24.0 versus 34.6 ± 21.8; P = 0.043). Patients with higher Cantril Ladder of Happiness scores reported higher psychosocial well-being (β = 12.9; P < 0.001) and sexual well-being (β = 16.94; P < 0.001). Conclusions: Happy patients demonstrated higher satisfaction levels and improved psychosocial and sexual well-being compared with unhappy patients. SES played a role in patient satisfaction and overall well-being. Further research is warranted to identify suitable interventions, such as screening and early referral, that can help improve patient-reported outcomes for patients undergoing breast reconstruction.
- 1 November 2024
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 93 (5) , 643-648
Resection Weight Formulas for Reduction Mammoplasty
Purpose: Estimating resection weight for patients undergoing reduction mammoplasty (RM) informs surgical planning and outcomes. Existing formulas have limitations that make insurance coverage and accurate surgical planning challenging. We identified the most commonly used scales to evaluate their accuracy in estimating resection weight by applying them to a database of patients to compare calculated and actual resection weights. Methods: A database search was conducted using combinations of relevant terms. A regression analysis was conducted using formulas with strong R 2 values (0.72–0.93) on a cohort of 1128 RM patients at a single institution. Results: A total of 570 articles were identified. Fourteen manuscripts (n = 2232 patients [3320 breasts]) were ultimately included for review. Data on incisional patterns, pedicle supply, and breast measurements, such as sternal notch to nipple distance (n = 8 [57.1%]) or nipple to inframammary fold distance (n = 5 [35.7%]), were recorded. R 2 values in our cohort (>500 g, n = 891; R 2 indeterminate). Conclusions: Our analysis suggests that formulas reporting strong R 2 values may have resulted from tailoring to surgeons' technique. Variation between cohorts is inevitable; however, we expect reliable results given our large sample. It is reasonable to conclude that existing formulas are not accurate representations of resection weights and thus are unreliable for surgical planning.
- 1 November 2024
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 93 (5) , 643-648
Resection Weight Formulas for Reduction Mammoplasty
Purpose: Estimating resection weight for patients undergoing reduction mammoplasty (RM) informs surgical planning and outcomes. Existing formulas have limitations that make insurance coverage and accurate surgical planning challenging. We identified the most commonly used scales to evaluate their accuracy in estimating resection weight by applying them to a database of patients to compare calculated and actual resection weights. Methods: A database search was conducted using combinations of relevant terms. A regression analysis was conducted using formulas with strong R 2 values (0.72–0.93) on a cohort of 1128 RM patients at a single institution. Results: A total of 570 articles were identified. Fourteen manuscripts (n = 2232 patients [3320 breasts]) were ultimately included for review. Data on incisional patterns, pedicle supply, and breast measurements, such as sternal notch to nipple distance (n = 8 [57.1%]) or nipple to inframammary fold distance (n = 5 [35.7%]), were recorded. R 2 values in our cohort (>500 g, n = 891; R 2 indeterminate). Conclusions: Our analysis suggests that formulas reporting strong R 2 values may have resulted from tailoring to surgeons' technique. Variation between cohorts is inevitable; however, we expect reliable results given our large sample. It is reasonable to conclude that existing formulas are not accurate representations of resection weights and thus are unreliable for surgical planning.
- 15 August 2024
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 93 (4) , e26-e35
Sterile Draping of Operative Microscopes in Breast Free Flaps and Surgical Site Infections
Background: Operative microscopes are traditionally draped in single-use plastic to prevent infection theoretically. The necessity of this routine in breast free flap surgery is unclear. Alternatively, sterile wrapping of microscope handles would reduce operating room waste and provide a more cost-effective and environmentally sustainable approach to sterility. This study aimed to determine whether the draping technique used during abdominally based free flaps (Ab-FF) influenced the rate of surgical site infections. Methods: We conducted a retrospective review of Ab-FF performed consecutively between March 2017 and August 2022. Patient demographics, comorbidities, perioperative data, and postoperative complications were collected. The primary outcomes included postoperative surgical site infections and environmental impact. Results: Of the 281 identified breasts reconstructed with Ab-FF, operating microscopes were sterilely covered with microscope drapes (n = 215) or handle covers (n = 66) composed of polyethylene-based plastic. Overall, postoperative infections occurred in 9.3% of cases (n = 26) in either the recipient breast (n = 11, 3.9%) or abdominal donor site (n = 15, 5.3%), primarily due to S. aureus and Streptococcus species. The handle (n = 6, 9.1%) and drape (n = 20, 9.3%) cohorts had similar infection rates with no sequelae of operative complications. In multivariate analysis, radiation was the only independent predictor of postoperative infection, while bilateral reconstructions were independently protective. Replacing a microscope drape with a handle reduces carbon emissions by 1276 grams of CO2 and direct costs by $7.84 per item. Conclusions: The principles of “Lean and Green” surgery prioritize reducing operating room generated waste to achieve financial and environmental sustainability. This cohort study of 281 breast free flaps demonstrates that switching from whole microscope draping to handle wrapping was not associated with an increased rate or odds of infection. Adopting a microscope handle wrapping protocol decreased the carbon footprint and operative costs. The results of this study offer evidence to support adoption and further exploration of pragmatic, cost-effective, and sustainable approaches to microsurgical breast reconstruction.
- 15 August 2024
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 93 (4) , e26-e35
Sterile Draping of Operative Microscopes in Breast Free Flaps and Surgical Site Infections
Background: Operative microscopes are traditionally draped in single-use plastic to prevent infection theoretically. The necessity of this routine in breast free flap surgery is unclear. Alternatively, sterile wrapping of microscope handles would reduce operating room waste and provide a more cost-effective and environmentally sustainable approach to sterility. This study aimed to determine whether the draping technique used during abdominally based free flaps (Ab-FF) influenced the rate of surgical site infections. Methods: We conducted a retrospective review of Ab-FF performed consecutively between March 2017 and August 2022. Patient demographics, comorbidities, perioperative data, and postoperative complications were collected. The primary outcomes included postoperative surgical site infections and environmental impact. Results: Of the 281 identified breasts reconstructed with Ab-FF, operating microscopes were sterilely covered with microscope drapes (n = 215) or handle covers (n = 66) composed of polyethylene-based plastic. Overall, postoperative infections occurred in 9.3% of cases (n = 26) in either the recipient breast (n = 11, 3.9%) or abdominal donor site (n = 15, 5.3%), primarily due to S. aureus and Streptococcus species. The handle (n = 6, 9.1%) and drape (n = 20, 9.3%) cohorts had similar infection rates with no sequelae of operative complications. In multivariate analysis, radiation was the only independent predictor of postoperative infection, while bilateral reconstructions were independently protective. Replacing a microscope drape with a handle reduces carbon emissions by 1276 grams of CO2 and direct costs by $7.84 per item. Conclusions: The principles of “Lean and Green” surgery prioritize reducing operating room generated waste to achieve financial and environmental sustainability. This cohort study of 281 breast free flaps demonstrates that switching from whole microscope draping to handle wrapping was not associated with an increased rate or odds of infection. Adopting a microscope handle wrapping protocol decreased the carbon footprint and operative costs. The results of this study offer evidence to support adoption and further exploration of pragmatic, cost-effective, and sustainable approaches to microsurgical breast reconstruction.
- 1 July 2024
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 93 (1) , 34-42
Acellular Dermal Matrix–Assisted, Prosthesis-Based Breast Reconstruction
Background: Acellular dermal matrices (ADMs) are frequently employed in immediate prosthesis-based breast reconstruction (iPBR) to provide structural support. Despite differences in ADM derivatives, few studies directly compare their outcomes in the setting of iPBR. We sought to conduct a large head-to-head study comparing 3 ADMs used across our institution. Methods: A multicenter retrospective review of patients undergoing iPBR with SurgiMend PRS (fetal bovine–derived; Integra Lifesciences, Princeton, NJ), AlloDerm (human-derived; LifeCell Corp, Bridgewater, NJ), or DermACELL (human-derived; Stryker Corp, Kalamazoo, MI) between January 2014 to July 2022 was performed. Primary outcomes included rates of unplanned explantation and total reconstructive failure. Secondary outcomes included 90-day postoperative complications and long-term rates of capsular contracture development. Results: A total of 738 patients (1228 breasts) underwent iPBR during the study period; 405 patients received DermACELL (54.9%), 231 received AlloDerm (31.3%), and 102 received SurgiMend PRS (13.8%). Rates of short-term complications, total reconstruction failure, reoperation within 90 days, capsular contracture, and unplanned explantation were comparable. These findings remained true upon multivariate analysis accounting for baseline differences between cohorts, whereby ADM type was not an independent predictor of any outcome of interest. Conversely, factors such as body mass index, diabetes mellitus, smoking history, neoadjuvant and adjuvant chemotherapy, adjuvant radiation, skin-sparing mastectomy, Wise pattern and periareolar incisions, use of tissue expanders, and a subpectoral plane of insertion were significant predictors of postoperative complications. Conclusion: Low rates of complications support the equivalency of fetal bovine and human-derived ADMs in iPBR. Patient characteristics and operative approach are likely more predictive of postoperative outcomes than ADM derivative alone.
- 1 July 2024
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 93 (1) , 34-42
Acellular Dermal Matrix–Assisted, Prosthesis-Based Breast Reconstruction
Background: Acellular dermal matrices (ADMs) are frequently employed in immediate prosthesis-based breast reconstruction (iPBR) to provide structural support. Despite differences in ADM derivatives, few studies directly compare their outcomes in the setting of iPBR. We sought to conduct a large head-to-head study comparing 3 ADMs used across our institution. Methods: A multicenter retrospective review of patients undergoing iPBR with SurgiMend PRS (fetal bovine–derived; Integra Lifesciences, Princeton, NJ), AlloDerm (human-derived; LifeCell Corp, Bridgewater, NJ), or DermACELL (human-derived; Stryker Corp, Kalamazoo, MI) between January 2014 to July 2022 was performed. Primary outcomes included rates of unplanned explantation and total reconstructive failure. Secondary outcomes included 90-day postoperative complications and long-term rates of capsular contracture development. Results: A total of 738 patients (1228 breasts) underwent iPBR during the study period; 405 patients received DermACELL (54.9%), 231 received AlloDerm (31.3%), and 102 received SurgiMend PRS (13.8%). Rates of short-term complications, total reconstruction failure, reoperation within 90 days, capsular contracture, and unplanned explantation were comparable. These findings remained true upon multivariate analysis accounting for baseline differences between cohorts, whereby ADM type was not an independent predictor of any outcome of interest. Conversely, factors such as body mass index, diabetes mellitus, smoking history, neoadjuvant and adjuvant chemotherapy, adjuvant radiation, skin-sparing mastectomy, Wise pattern and periareolar incisions, use of tissue expanders, and a subpectoral plane of insertion were significant predictors of postoperative complications. Conclusion: Low rates of complications support the equivalency of fetal bovine and human-derived ADMs in iPBR. Patient characteristics and operative approach are likely more predictive of postoperative outcomes than ADM derivative alone.